Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of mice and successfully edit a gene associated with Alzheimer's disease.
Researchers have developed drug-carrying nanoparticles that cross the blood-brain barrier, allowing for more effective delivery to the brain than conventional medications. The nanoparticles can get into tumors and kill glioblastoma brain cancer cells.
Novel sensors made from modified carbon nanotubes can visualize the release of dopamine from neurons with unprecedented resolution.
Amyloid plaques can cling to newly developed bowl-shaped nanoparticles. The findings provide a new way to study the Alzheimer's related plaques and provides novel treatment options for dementia.
A new nanoparticle drug-delivery system resulted in unprecedented siRNA penetration across the intact blood-brain barrier. Researchers say the system could help doctors to treat secondary injuries associated with TBI that can result in Alzheimer's and other neurodegenerative disorders.
Researchers have developed a new approach to prevent amyloid plaque formation by engineering a nanodevice that captures the peptides before they can assemble. The silica nanodevice might be a new tool in the treatment and prevention of Alzheimer's disease and other neurodegenerative diseases associated with amyloid-beta.
Newly designed microbots can deliver vital drugs throughout the human body. The microbots can traverse the body and penetrate bodily mucus to efficiently deliver medications to target sites.
Researchers use nanotech to enhance vision in mice, enabling them to see infrared light as well as visible light.
A new device that uses fast flowing fluids to insert nanotubes into the brain may be used to help treat a number of neurological diseases, researchers say.